Premium
Genetic risk of hepatocellular carcinoma in patients with hepatitis C virus: A case control study
Author(s) -
Tomoda Takeshi,
Nouso Kazuhiro,
Sakai Akiko,
Ouchida Mamoru,
Kobayashi Sayo,
Miyahara Koji,
Onishi Hideki,
Nakamura Shinichiro,
Yamamoto Kazuhide,
Shimizu Kenji
Publication year - 2012
Publication title -
journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.214
H-Index - 130
eISSN - 1440-1746
pISSN - 0815-9319
DOI - 10.1111/j.1440-1746.2011.06948.x
Subject(s) - hepatocellular carcinoma , medicine , single nucleotide polymorphism , odds ratio , hepatitis c virus , gastroenterology , risk factor , case control study , oncology , genotype , virus , immunology , gene , biology , genetics
Backgroud and Aim: Chronic hepatitis C virus (HCV) infection is a well known risk factor for hepatocellular carcinoma (HCC). The aim of this study is to elucidate the genetic risk of development and recurrence of HCC in patients with HCV. Methods: A total of 468 patients with HCV, including 265 with HCC were enrolled. We genotyped 88 single nucleotide polymorphisms (SNPs) in 81 genes expected to influence hepatocarcinogenesis using the iPLEX assay. Risk of HCC was clarified by stratifying patients into risk groups based on the multiplied odds ratio (MOR) for SNPs associated with HCC, and the cumulative effects on the development and recurrence of HCC were analyzed. Results: Six SNPs associated with risk of HCC were identified (OR range: 0.29–1.76). These included novel SNPs for hepatocarcinogenesis with HCV CCND2 rs1049606, RAD23B rs1805329, CEP164 rs573455, and GRP78rs430397 in addition to the known SNPs MDM2 rs2279744 and ALDH2 rs671. MOR analysis revealed that the highest risk group exerted about a 19‐fold higher relative OR compared with the lowest risk group ( P = 1.08 × 10 −5 ). Predicted 10‐year HCC risk ranged from 1.7% to 96% depending on the risk group and the extent of fibrosis. Recurrence‐free survival of radiofrequency ablation‐treated HCC in the high risk group ( n = 53) was lower than that of low risk group ( n = 58, P = 0.038). Conclusion: Single nucleotide polymorphisms of CCND2, RAD23B, GRP78, CEP164, MDM2, and ALDH2 genes were significantly associated with development and recurrence of HCC in Japanese patients with HCV.